{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:58:41Z","timestamp":1787003921126,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2006,9,4]],"date-time":"2006-09-04T00:00:00Z","timestamp":1157328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,9,4]],"date-time":"2006-09-04T00:00:00Z","timestamp":1157328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2006,10,1]]},"DOI":"10.1038\/sj.bmt.1705485","type":"journal-article","created":{"date-parts":[[2006,9,4]],"date-time":"2006-09-04T14:21:33Z","timestamp":1157379693000},"page":"547-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide"],"prefix":"10.1038","volume":"38","author":[{"given":"S","family":"Corbacioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"H\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Lahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"St\u00f6hr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A S","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,9,4]]},"reference":[{"issue":"Suppl 1","key":"BF1705485_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1034\/j.1399-3046.1999.00063.x","volume":"3","author":"A Fasth","year":"1999","unstructured":"Fasth A, Porras O . Human malignant osteopetrosis: pathophysiology, management and the role of bone marrow transplantation. Pediatr Transplant 1999; 3 (Suppl 1): 102\u2013107.","journal-title":"Pediatr Transplant"},{"key":"BF1705485_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/77131","volume":"25","author":"A Frattini","year":"2000","unstructured":"Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinun M, Mattsson JP et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 2000; 25: 343\u2013346.","journal-title":"Nat Genet"},{"key":"BF1705485_CR3","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1359\/jbmr.2003.18.10.1740","volume":"18","author":"A Frattini","year":"2003","unstructured":"Frattini A, Pangrazio A, Susani L, Sobacchi C, Mirolo M, Abinun M et al. Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J Bone Miner Res 2003; 18: 1740\u20131747.","journal-title":"J Bone Miner Res"},{"key":"BF1705485_CR4","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1093\/hmg\/10.17.1767","volume":"10","author":"C Sobacchi","year":"2001","unstructured":"Sobacchi C, Frattini A, Orchard P, Porras O, Tezcan I, Andolina M et al. The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum Mol Genet 2001; 10: 1767\u20131773.","journal-title":"Hum Mol Genet"},{"key":"BF1705485_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0092-8674(01)00206-9","volume":"104","author":"U Kornak","year":"2001","unstructured":"Kornak U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 2001; 104: 205\u2013215.","journal-title":"Cell"},{"key":"BF1705485_CR6","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1093\/hmg\/10.25.2861","volume":"10","author":"E Cleiren","year":"2001","unstructured":"Cleiren E, Benichou O, Van Hul E, Gram J, Bollerslev J, Singer FR et al. Albers\u2013Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet 2001; 10: 2861\u20132867.","journal-title":"Hum Mol Genet"},{"key":"BF1705485_CR7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00439-002-0861-9","volume":"112","author":"AB Campos-Xavier","year":"2003","unstructured":"Campos-Xavier AB, Saraiva JM, Ribeiro LM, Munnich A, Cormier-Daire V . Chloride channel 7 (CLCN7) gene mutations in intermediate autosomal recessive osteopetrosis. Hum Genet 2003; 112: 186\u2013189.","journal-title":"Hum Genet"},{"key":"BF1705485_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1056\/NEJM198003273021301","volume":"302","author":"PF Coccia","year":"1980","unstructured":"Coccia PF, Krivit W, Cervenka J, Clawson C, Kersey JH, Kim TH et al. Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med 1980; 302: 701\u2013708.","journal-title":"N Engl J Med"},{"key":"BF1705485_CR9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/sj.bmt.1704194","volume":"32","author":"GJ Driessen","year":"2003","unstructured":"Driessen GJ, Gerritsen EJ, Fischer A, Fasth A, Hop WC, Veys P et al. Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant 2003; 32: 657\u2013663.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705485_CR10","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1182\/blood.V99.9.3458","volume":"99","author":"AS Schulz","year":"2002","unstructured":"Schulz AS, Classen CF, Mihatsch WA, Sigl-Kraetzig M, Wiesneth M, Debatin KM et al. HLA-haploidentical blood progenitor cell transplantation in osteopetrosis. Blood 2002; 99: 3458\u20133460.","journal-title":"Blood"},{"key":"BF1705485_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1365-2141.2003.04739.x","volume":"124","author":"CG Steward","year":"2004","unstructured":"Steward CG, Pellier I, Mahajan A, Ashworth MT, Stuart AG, Fasth A et al. Severe pulmonary hypertension: a frequent complication of stem cell transplantation for malignant infantile osteopetrosis. Br J Haematol 2004; 124: 63\u201371.","journal-title":"Br J Haematol"},{"key":"BF1705485_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255\u2013267.","journal-title":"Ann Intern Med"},{"key":"BF1705485_CR13","first-page":"3599","volume":"92","author":"E Carreras","year":"1998","unstructured":"Carreras E, Bertz H, Arcese W, Vernant JP, Tomas JF, Hagglund H et al. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Blood 1998; 92: 3599\u20133604.","journal-title":"Blood"},{"key":"BF1705485_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2165\/00003495-199345020-00007","volume":"45","author":"KJ Palmer","year":"1993","unstructured":"Palmer KJ, Goa KL . Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders. Drugs 1993; 45: 259\u2013294.","journal-title":"Drugs"},{"key":"BF1705485_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1182\/blood.V100.1.334","volume":"100","author":"G Eissner","year":"2002","unstructured":"Eissner G, Multhoff G, Gerbitz A, Kirchner S, Bauer S, Haffner S et al. Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide. Blood 2002; 100: 334\u2013340.","journal-title":"Blood"},{"key":"BF1705485_CR16","doi-asserted-by":"crossref","first-page":"146a","DOI":"10.1182\/blood.V94.1.146.413k39_146_155","volume":"94","author":"A Falanga","year":"1999","unstructured":"Falanga A, Marchetti M, Vignoli A, Barbui T . Defibrotide (DF) modulates tissue factor expression by microvascular endothelial cells. Blood 1999; 94: 146a.","journal-title":"Blood"},{"key":"BF1705485_CR17","doi-asserted-by":"crossref","first-page":"53a","DOI":"10.1182\/blood.V96.13.4261","volume":"96","author":"A Falanga","year":"2000","unstructured":"Falanga A, Marchetti M, Vignoli A, Barbui T . Impact of defibrotide on the fibrinolytic and procoagulant properties of endothelial cells from macro- and micro-vessels. Blood 2000; 96: 53a.","journal-title":"Blood"},{"key":"BF1705485_CR18","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/sj.leu.2403004","volume":"17","author":"A Falanga","year":"2003","unstructured":"Falanga A, Vignoli A, Marchetti M, Barbui T . Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells. Leukemia 2003; 17: 1636\u20131642.","journal-title":"Leukemia"},{"key":"BF1705485_CR19","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1046\/j.1365-2141.2000.02475.x","volume":"111","author":"R Chopra","year":"2000","unstructured":"Chopra R, Eaton JD, Grassi A, Potter M, Shaw B, Salat C et al. Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. Br J Haematol 2000; 111: 1122\u20131129.","journal-title":"Br J Haematol"},{"key":"BF1705485_CR20","first-page":"737","volume":"92","author":"PG Richardson","year":"1998","unstructured":"Richardson PG, Elias AD, Krishnan A, Wheeler C, Nath R, Hoppensteadt D et al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood 1998; 92: 737\u2013744.","journal-title":"Blood"},{"key":"BF1705485_CR21","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","volume":"100","author":"PG Richardson","year":"2002","unstructured":"Richardson PG, Murakami C, Jin Z, Warren DL, Momtaz P, Hoppensteadt D et al. Multi-institutional use of defibrotide in 88 patients post stem cell transplant with severe veno-occlusive disease and multi-system organ failure; response without significant toxicity in a high risk population and factors predictive of outcome. Blood 2002; 100: 4337\u20134343.","journal-title":"Blood"},{"key":"BF1705485_CR22","first-page":"112a","volume":"100","author":"PG Richardson","year":"2002","unstructured":"Richardson PG, Soiffer R, Antin JH, Vredenburgh J, Kurtzberg J, Martin PL et al. Defibrotide (DF) appears effective and safe in a phase II, randomized study of patients (pts) with severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT). Blood 2002; 100: 112a.","journal-title":"Blood"},{"key":"BF1705485_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","volume":"33","author":"S Corbacioglu","year":"2004","unstructured":"Corbacioglu S, Greil J, Peters C, Wulffraat N, Laws HJ, Dilloo D et al. Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant 2004; 33: 189\u2013195.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705485_CR24","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778\u2013783.","journal-title":"Transplantation"},{"key":"BF1705485_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF01695888","volume":"66","author":"E Carreras","year":"1993","unstructured":"Carreras E, Granena A, Navasa M, Bruguera M, Marco V, Sierra J et al. On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease. Ann Hematol 1993; 66: 77\u201380.","journal-title":"Ann Hematol"},{"key":"BF1705485_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","volume":"10","author":"Y Chalandon","year":"2004","unstructured":"Chalandon Y, Roosnek E, Mermillod B, Newton A, Ozsahin H, Wacker P et al. Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2004; 10: 347\u2013354.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705485_CR27","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1182\/blood-2003-10-3612","volume":"103","author":"B Versluys","year":"2004","unstructured":"Versluys B, Bhattacharaya R, Steward C, Cornish J, Oakhill A, Goulden N . Prophylaxis with defibrotide prevents veno-occlusive disease in stem cell transplantation after gemtuzumab ozogamicin exposure. Blood 2004; 103: 1968.","journal-title":"Blood"},{"key":"BF1705485_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.bmt.1704069","volume":"32","author":"CC Barker","year":"2003","unstructured":"Barker CC, Butzner JD, Anderson RA, Brant R, Sauve RS . Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2003; 32: 79\u201387.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705485_CR29","first-page":"1396","volume":"90","author":"S Cesaro","year":"2005","unstructured":"Cesaro S, Pillon M, Talenti E, Toffolutti T, Calore E, Tridello G et al. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Haematologica 2005; 90: 1396\u20131404.","journal-title":"Haematologica"},{"key":"BF1705485_CR30","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/sj.bmt.1701764","volume":"23","author":"D Przepiorka","year":"1999","unstructured":"Przepiorka D, Khouri I, Thall P, Mehra R, Lee MS, Ippoliti C et al. Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia. Bone Marrow Transplant 1999; 23: 977\u2013981.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705485_CR31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S1083-8791(99)70006-6","volume":"5","author":"JL Lee","year":"1999","unstructured":"Lee JL, Gooley T, Bensinger W, Schiffman K, McDonald GB . Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome. Biol Blood Marrow Transplant 1999; 5: 306\u2013315.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705485_CR32","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/sj.bmt.1702016","volume":"24","author":"L Worth","year":"1999","unstructured":"Worth L, Tran H, Petropoulos D, Culbert S, Mullen C, Roberts W et al. Hematopoietic stem cell transplantation for childhood myeloid malignancies after high-dose thiotepa, busulfan and cyclophosphamide. Bone Marrow Transplant 1999; 24: 947\u2013952.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705485_CR33","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1002\/cncr.20227","volume":"100","author":"F Fagioli","year":"2004","unstructured":"Fagioli F, Biasin E, Mastrodicasa L, Sandri A, Ferrero I, Berger M et al. High-dose thiotepa and etoposide in children with poor-prognosis brain tumors. Cancer 2004; 100: 2215\u20132221.","journal-title":"Cancer"},{"key":"BF1705485_CR34","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/sj.bjc.6603097","volume":"94","author":"ME de Jonge","year":"2006","unstructured":"de Jonge ME, Huitema AD, Beijnen JH, Rodenhuis S . High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy. Br J Cancer 2006; 94: 1226\u20131230.","journal-title":"Br J Cancer"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705485","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705485.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705485.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T20:11:16Z","timestamp":1648066276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,4]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,10,1]]}},"alternative-id":["BF1705485"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705485","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,4]]},"assertion":[{"value":"26 June 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}